Bdenza is a prescription medication containing enzalutamide, a non-steroidal anti-androgen used to treat metastatic castration-resistant prostate cancer (mCRPC).
Composition: Bdenza contains 80mg of enzalutamide, a selective androgen receptor antagonist.
Mechanism of Action: Enzalutamide works by blocking the action of androgens (male hormones) on the prostate cancer cells. This helps to slow or stop the growth of prostate cancer cells.
Uses: Bdenza is used to treat:
- Metastatic castration-resistant prostate cancer (mCRPC) in men who have previously received androgen deprivation therapy (ADT).
Dosage: The recommended dosage of Bdenza is:
- 80mg taken orally once daily, with or without food.
Side Effects: Common side effects of Bdenza may include:
- Fatigue
- Nausea
- Back pain
- Constipation
- Decreased libido
- Hot flashes
- Joint pain
- Muscle weakness
- Headache
- Dizziness
Recommendation: Bdenza is recommended for men who have already received androgen deprivation therapy (ADT) and have metastatic castration-resistant prostate cancer (mCRPC). It is important to discuss the potential benefits and risks of Bdenza with your doctor before starting treatment.
Important Note:
- Bdenza is a prescription medication and should only be used under the guidance of a healthcare provider.
- Patients taking Bdenza should not donate blood or sperm during treatment and for at least 6 months after stopping treatment.
- Patients taking Bdenza may experience changes in their mental health, such as depression, anxiety, or mood swings. Patients should report any changes in their mental health to their doctor.
- Patients taking Bdenza should not drive or operate heavy machinery if they experience dizziness or somnolence.
- Patients taking Bdenza should not take any other medications without consulting their doctor first.
Reviews
There are no reviews yet.